Cmed Medical Services offers comprehensive and dynamic support to Cmed’s Clinical Services CRO, including:
> Medical and scientific contribution to draft clinical study protocols
> Medical and safety monitoring of clinical studies.
> Medical writing support.
> Support to Cmed Consultancy Services.
Experience is the difference
Our seasoned medical staff have extensive experience in the pharmaceutical and CRO industry, including:
> All phases of drug development (TM, I-IV) – strongest in first-in-human
to Phase II POC clinical studies.
> Multiple therapy areas, especially oncology and rare diseases,
immune-inflammation, respiratory and CNS disorders.
> Studies involving a wide variety of compounds including: small molecular
entities (NCEs), biopharmaceuticals (monoclonal antibodies, antibody
fragments, antibody drug conjugates and immune check point inhibitors),
vaccines, cell therapy (including CAR-T cells) and gene therapy products.
This group is supported by a network of KOLs and contacts who can provide advice on a project-by-project basis.
For more information contact:
Chief Medical Officer
+44 (0)1403 758270